Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.82
(2.92%)
CNY 8.82
(2.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 302.17 Million CNY | -22.64% |
| 2022 | 250.43 Million CNY | 56.44% |
| 2021 | 160.08 Million CNY | 56.57% |
| 2020 | 102.24 Million CNY | 35.58% |
| 2019 | 75.41 Million CNY | 34.22% |
| 2018 | 56.18 Million CNY | -3.79% |
| 2017 | 58.39 Million CNY | 21.13% |
| 2016 | 48.21 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 32.23 Million CNY | -11.64% |
| 2024 Q2 | 36.56 Million CNY | 17.02% |
| 2023 Q1 | 47.4 Million CNY | -19.02% |
| 2023 Q3 | 36.93 Million CNY | -49.33% |
| 2023 Q2 | 72.9 Million CNY | 53.79% |
| 2023 FY | 193.72 Million CNY | -22.64% |
| 2023 Q4 | 36.48 Million CNY | -1.23% |
| 2022 Q2 | 75.77 Million CNY | 37.53% |
| 2022 Q4 | 58.53 Million CNY | -4.07% |
| 2022 Q1 | 55.09 Million CNY | 4.25% |
| 2022 Q3 | 61.02 Million CNY | -19.47% |
| 2022 FY | 250.43 Million CNY | 56.44% |
| 2021 Q1 | 30.1 Million CNY | 31.56% |
| 2021 Q2 | 43.42 Million CNY | 44.27% |
| 2021 Q3 | 33.7 Million CNY | -22.4% |
| 2021 Q4 | 52.85 Million CNY | 56.82% |
| 2021 FY | 160.08 Million CNY | 56.57% |
| 2020 Q3 | 25.65 Million CNY | -24.4% |
| 2020 Q1 | 19.76 Million CNY | -24.27% |
| 2020 FY | 102.24 Million CNY | 35.58% |
| 2020 Q4 | 22.87 Million CNY | -10.83% |
| 2020 Q2 | 33.93 Million CNY | 71.69% |
| 2019 Q4 | 26.1 Million CNY | 0.0% |
| 2019 FY | 75.41 Million CNY | 34.22% |
| 2019 Q1 | 16.16 Million CNY | 0.0% |
| 2018 FY | 56.18 Million CNY | -3.79% |
| 2017 FY | 58.39 Million CNY | 21.13% |
| 2016 FY | 48.21 Million CNY | 0.0% |